ArticlePloS one2026
Phenotypic and molecular characterization of K64 putative hypervirulent carbapenem-resistant Klebsiella pneumoniae.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesAlthough K64-type carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKp) has been reported, its molecular characteristics remain unclear. This study aimed to characterize the phenotypic and molecular features of K64 putative hypervirulent CR-K. pneumoniae (phvKp)..
methodsTwo K64 putative hypervirulent CR-K. pneumoniae isolates were recovered from a patient in the emergency intensive care unit of a Chinese teaching hospital. Antimicrobial susceptibility testing was performed using broth microdilution method. Multilocus sequence typing (MLST) was used for molecular typing. Virulence was assessed using a mouse infection model, and whole-genome sequencing was performed to analyze resistance and virulence genes.
resultsBoth isolates were resistant to aztreonam, cephalosporins, carbapenems, quinolones, and aminoglycosides, but susceptible to trimethoprim/sulfamethoxazole, colistin, tigecycline, and ceftazidime/avibactam. MLST identified both isolates as ST11. The mouse infection model showed elevated virulence of two clinical isolates, which was significantly higher than that of the classical non-hypervirulent reference strain ATCC 13883. Genomic analysis identified 133 virulence- and pathogen-associated genes, including those involved in fimbriae synthesis, iron acquisition, and enterobactin production. Both isolates harbored the rmpA gene, but string tests were negative. Sequence alignment revealed >80% similarity among 13 rmpA-harboring IncHI1B plasmids.
conclusionsK64 ST11-type phvKp has emerged in China, exhibiting multidrug resistance and putative hypervirulence characteristics. The increase in virulence of K.pneumoniae involves multiple factors, and these factors act independently or the synergistic effect leads to elevated virulence potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.